T-cell activation implicated in the slower progression of HIV-2

  • Agenzia Zoe
  • Medical News
Access to the full content of this site is available only to registered healthcare professionals. Access to the full content of this site is available only to registered healthcare professionals.

Key messages

  • HIV-2 had lower HIV RNA levels and a higher proportion of naïve B-cells than HIV-1 infected patients.
  • HIV-2 was characterized by higher proportions of CD8+CD28+ and lower proportions of CD8+PD-1+ T-cells than HIV-1 infection.
  • Findings may partly explain why HIV-2 is less pathogenic and develop more slowly than HIV-1.

In a cross-sectional study, 63 HIV-2 (47 viremic and 16 aviremic), 83 HIV-1, and 26 HIV negative individuals were enrolled from an HIV clinic at Hospital Nacional Simão Mendes in Bissau, Guinea-Bissau. All infected participants were ART naïve.

The aim of the authors was to further understand the importance of HIV-2 RNA levels and immune perturbations in HIV-1 and HIV-2 infection. Indeed, as known, HIV-2 is less pathogenic than HIV-1, and HIV-2 induced immunodeficiency may be different from that caused by HIV-1.

After standardizing for sex, age and CD4+ T cell count, HIV RNA was lower for HIV-2 than for HIV-1 infected patients (p

Flow cytometry was used to analyze T-cells (maturation, activation and regulation) and B-cells (maturation and activation). In adjusted analysis, there was no difference in T-cell maturation between HIV-1 and HIV-2.

T-cell regulation (Tregs-profiles) was perturbed in HIV infected patients, but no difference was observed between HIV-1 and HIV-2.

Both HIV types were associated with an increased proportion of T-cells positive for activation markers. Interestingly, HIV-2 infected patients had higher proportions of CD8+CD28+ (p=0.008) and lower levels of CD8+PD-1+ T cells (p=0.001) than HIV-1 infected patients, independently from HIV RNA levels. This may result in more effective CD8+ T-cell responses to better control viral replication and slow CD4+ T cell decline.

Finally, in line with previous studies, the authors reported differences in B-cells. HIV-2 infected patients had a higher proportion of naïve B-cells among patients with CD4+ T-cell count below 350 cells/µL (p=0.001). HIV-1 and HIV-2 had a similarly high proportion of CD21low B-cells.

Although the reasons remain unknown, the lower viral load and the differences of T and B-cell phenotype between HIV types reported in this study may help to explain why HIV-2 has a slower disease progression than HIV-1 infected patients.


Please confirm your acceptance

To gain full access to GPnotebook please confirm:

By submitting here you confirm that you have accepted Terms of Use and Privacy Policy of GPnotebook.